Who
Greg Cavers
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Helus Pharma.
In numbers
- Trades disclosed
- 1
- Buys
- 1
- Sells
- 0
- Bought
- $39K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Sep 2026
- Last trade
- 29 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Sep – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Sep 2026filed 1 Oct 2026 | HELP Helus PharmaBiotechnology | SEC FORM 4 Bought | $39K3,000 at $12.91 | filing |
News
Helus Pharma Appoints Dr. Suresh Durgam to Board of DirectorsHELP · recorder.ca · 15 Oct 2026Helus Pharma to Host Investor Presentation on October 21, 2026HELP · simcoereformer.ca · 8 Oct 2026
0 headlines in the last 90 days name Greg Cavers; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.